k.dahlberg

TL2 · Cali

Contributes reviews on supplier material. Based in Cali.

Joined 8 November 2024 · last posted 18h

83 posts, newest first. Showing up to 150.

Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #24 · Practice › Side effects · 27 Jul 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Historical amylin analogues and what happened to them Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 27 Jul 2026 · 0 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
Seven-day rolling means and why weekly readings mislead Replied, post #95 · Outcomes › Progress reports · 24 Jul 2026 · 9 likes Seven-day rolling looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Journal club: what we got wrong in an earlier session Replied, post #108 · Evidence › Journal club · 22 Jul 2026 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
Seven-day rolling means and why weekly readings mislead Replied, post #76 · Outcomes › Progress reports · 21 Jul 2026 · 10 likes State the method before the numbers. Same scale, same time of day, same conditions — without that a series is a collection of readings rather than a measurement. The…
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #15 · Analytics › COA interpretation · 16 Jul 2026 · 0 likes Everything in post #11 holds. The case it does not cover is the one I have. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate…
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #25 · Sourcing › Vendor reports · 13 Jul 2026 · 1 like Taking post #22 at face value and following it one step further. Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is…
Which categories are strict and which are relaxed, honestly Replied, post #7 · marked as the solution · Start Here › Welcome · 11 Jul 2026 · 14 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
Prescription requirements and telehealth models — a second dataset Replied, post #74 · Sourcing › Regulatory · 21 Jun 2026 · 3 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #75 · Devices › Syringes & needles · 17 Jun 2026 · 5 likes Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same volume equally well; the smaller one lets you see what you are…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #96 · Outcomes › Body composition · 16 Jun 2026 · 0 likes Taking post #95 at face value and following it one step further. The strongest argument against my own position on Lean mass preservation, stated as well as I can state…
Publication patterns in the BPC-157 literature, examined Replied, post #7 · Compounds › Repair & healing peptides · 3 Jun 2026 · 32 likes Right, and stated more narrowly than I would have dared to state it.
Revisiting: The best-written scientific paper you have read Replied, post #12 · Lounge › Off topic · 2 Jun 2026 · 11 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
Private prescribing in the UK: what is actually involved Replied, post #20 · Regional › UK & Ireland · 21 May 2026 · 20 likes That is the distinction I keep failing to hold on to. Written down now.
CJC-1295 with and without DAC: what the modification does Replied, post #61 · Compounds › Secretagogues & GH axis · 19 May 2026 · 0 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
Moderation log format change Replied, post #53 · Meta › Announcements · 15 May 2026 · 19 likes Noting appreciation rather than asking anything. Several years of unpaid work on something with no leaderboard and a public log of your mistakes is a peculiar thing to…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #44 · Evidence › Journal club · 10 May 2026 · 1 like Helpful, and short, which on this subject is harder than long.
Historical amylin analogues and what happened to them Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 7 May 2026 · 31 likes Post #2 put the caveat in the right place and I want to underline it. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #23 · Analytics › Home & field testing · 6 May 2026 · 22 likes I would call the community position on Reflectance and photometric devices likely rather than established, and I would be comfortable defending that hedge.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #22 · Practice › Reconstitution · 22 Apr 2026 · 1 like Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
Why the timeline is on the right and not the left — what changed since Replied, post #23 · Meta › Site feedback · 20 Apr 2026 · 14 likes Answering the question post #21 raises rather than the one it answers. Suggestion rather than complaint: the vendor pages carry a review date, and topics do not. A…
Spike-and-recover accuracy for a peptide assay Replied, post #30 · Analytics › Method validation · 7 Apr 2026 · 1 like Counterpoint on spike-and-recover accuracy, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #28 · Lounge › Introductions · 10 Mar 2026 · 9 likes Nice to meet you. Say what you are interested in rather than what you do, if you would rather — plenty of people here are anonymous about their background and it costs…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #5 · Clinical › Comorbidities · 9 Mar 2026 · 31 likes Noted, and thank you for writing it out rather than summarising it.
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #40 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2026 · 1 like On post #38 — agreed on the reasoning, with one qualification. I would keep nausea profile of amylin analogues and the decision it usually gets used for separate in…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #102 · Access › Pricing · 28 Feb 2026 · 6 likes On post #99 — agreed on the reasoning, with one qualification. The bit of Price changes that nobody enjoys is that the answer changes depending on what you are trying…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #133 · Practice › Dosing & titration · 22 Feb 2026 · 0 likes Answering the question post #131 raises rather than the one it answers. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #38 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes Adding the measurement that post #37 says would settle it. Adducts: I have looked for the primary source twice and failed twice. Either it does not exist or it is…
Trifluoroacetate content and its consequences Replied, post #81 · Analytics › Impurities & related substances · 4 Feb 2026 · 1 like Everything in post #77 holds. The case it does not cover is the one I have. The practical version of trifluoroacetate content is three sentences long. The rigorous…
Waist circumference technique and its repeatability Replied, post #45 · Outcomes › Progress reports · 30 Jan 2026 · 0 likes The arithmetic on waist circumference technique is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone…
Reading a home test result without over-claiming — what changed since Started this topic · Analytics › Home & field testing · 26 Jan 2026 · 26 likes On the subject in the title: Reading a home test result without over-claiming — what changed since Working notes rather than a conclusion. What changes if the standard…
Reading an interaction checker output critically Replied, post #73 · Practice › Interactions · 23 Dec 2025 · 1 like A note on scope: what I am saying about reading an interaction checker output applies to the case in the first post and I would not extend it further without checking.
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #20 · Compounds › Retatrutide · 1 Dec 2025 · 9 likes Narrowing post #19, because the general version has more than one answer. The evidence status here should be stated in the first line of any post about it rather than…
Reading SURMOUNT-1 without the press release Replied, post #78 · Compounds › Tirzepatide · 25 Nov 2025 · 23 likes The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale, which is why that trial carries more weight than its size…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #43 · Sourcing › Regulatory · 22 Nov 2025 · 0 likes I would rather this thread reach "we do not know" about Pharmaceutical compounding rules than reach a confident answer that nobody can support when asked.
Availability by country, dated, with primary sources Replied, post #66 · Access › International · 19 Nov 2025 · 16 likes What would change my mind on availability is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #26 · Start Here › How to Ask · 25 Oct 2025 · 26 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
The anatomy of a question that gets answered within an hour — the long version Replied, post #8 · Start Here › How to Ask · 18 Oct 2025 · 0 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
When to stop reading forums, including this one Replied, post #33 · Wellbeing › Mental health · 5 Oct 2025 · 10 likes Adding thanks rather than a view. I do not have a view worth the space.
Payment method and the leverage it gives you, ranked Replied, post #64 · Sourcing › Payments · 23 Sep 2025 · 30 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #34 · Compounds › Oral incretins · 3 Sep 2025 · 8 likes Noted, and I have changed what I was going to do on the strength of it.
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #21 · Practice › Storage & stability · 6 Aug 2025 · 0 likes Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 6 Aug 2025 · 0 likes Small correction to my own earlier position on cagrisema phase 2 paper. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
A ten-fold dose error caught before injection — one year on Replied, post #148 · Devices › Syringes & needles · 5 Aug 2025 · 16 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #23 · Compounds › Secretagogues & GH axis · 30 Jul 2025 · 2 likes Post #19 put the caveat in the right place and I want to underline it. Reconstitution volumes in this family are often small enough that dead volume in the syringe is a…
About the Administration category Replied, post #6 · Practice › Administration · 22 Jul 2025 · 5 likes Sharps disposal is the part of this that gets least attention and is genuinely a legal question in some jurisdictions rather than a matter of preference. This is the…
Cagrilintide molecular characteristics and analytical considerations Started this topic · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 43 likes Cagrilintide molecular characteristics and analytical considerations — setting out what I have, and where I think it stops being reliable. A methods question rather…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #65 · Evidence › Journal club · 6 Jul 2025 · 1 like The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Nothing above…
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #19 · Data & Tools › Datasets · 30 Jun 2025 · 14 likes Whether an aggregate has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #70 · Compounds › Retatrutide · 16 Jun 2025 · 1 like Reading back through the Retatrutide mass and identity threads from last year, the same three questions come up every time and only one of them has ever been answered…
Pre-registering a personal experiment, seriously Replied, post #58 · Research Methods › N-of-1 designs · 30 May 2025 · 3 likes Two people in this thread mean different things by pre-registering a personal experiment and are disagreeing about the definition while believing they are disagreeing…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 28 May 2025 · 28 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
Half-life, steady state, and accumulation worked through Replied, post #32 · Pharmacology › Pharmacokinetics · 28 May 2025 · 6 likes Post #30 describes the usual case. This is about the unusual one. Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A…
A report I filed that turned out to be wrong, and the correction Replied, post #66 · Sourcing › Vendor reports · 23 May 2025 · 4 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report. I have deliberately not…
Requesting a page: what makes a good request Replied, post #72 · Documentation › Wiki requests · 26 Apr 2025 · 7 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. That is all I can say without guessing.
Carryover and the ghost peak from last week's standard Replied, post #68 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 20 likes I would rather this thread reach "we do not know" about carryover than reach a confident answer that nobody can support when asked.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #86 · Access › International · 8 Mar 2025 · 28 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #20 · Practice › Reconstitution · 8 Mar 2025 · 12 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Second pass at: Regression to the mean in progress reports Replied, post #61 · Research Methods › Statistics · 19 Feb 2025 · 7 likes No disagreement from me. Posting only so the question does not look ignored.
Checking someone else's arithmetic: a worked example thread Replied, post #23 · Practice › Reconstitution · 19 Feb 2025 · 28 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
A page that has drifted out of date and needs a maintainer Replied, post #63 · Documentation › Wiki requests · 12 Feb 2025 · 25 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #64 · Evidence › Meta-analyses · 6 Feb 2025 · 32 likes Quality assessment of included trials should change the analysis rather than sit beside it. A sensitivity analysis excluding the weakest studies is the minimum.
What changed in 2026, by region Replied, post #102 · Access › International · 26 Jan 2025 · 1 like Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
Protein density versus volume when you cannot eat much Replied, post #22 · Nutrition & Training › Protein & intake · 26 Jan 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
Criticising the method without criticising the authors Replied, post #34 · Evidence › Study critique · 24 Jan 2025 · 0 likes Criticising the method without criticising: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #7 · Compounds › Retatrutide · 20 Jan 2025 · 0 likes This follows post #4 rather than contradicting it. Summarising the Triple agonism thread so far, since it is long and the answer is buried: the first reply has the…
Telehealth prescribing models in the US Replied, post #43 · Regional › North America · 8 Jan 2025 · 0 likes The practical version of telehealth prescribing models is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #98 · Access › Insurance & coverage · 1 Jan 2025 · 0 likes Second-hand on Step therapy requirements, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Coming back to: When to suspect the method rather than the sample Replied, post #123 · Analytics › Method validation · 24 Dec 2024 · 24 likes Adding the measurement that post #122 says would settle it. The most useful single question about a method: what would it fail to detect? Every method has an answer and…
Building a sensible monitoring schedule with your prescriber Replied, post #97 · Clinical › Bloodwork · 22 Dec 2024 · 14 likes Understood. Thank you for being specific about the limits of it.
Building a sensible monitoring schedule with your prescriber Replied, post #72 · Clinical › Bloodwork · 21 Dec 2024 · 0 likes Nobody has said the unglamorous part of building a sensible monitoring schedule yet, so: most of the variation is explained by things that are boring to write about and…
Body image changing more slowly than the body Replied, post #43 · Wellbeing › Mental health · 15 Dec 2024 · 27 likes Coming back to post #41, because the follow-up matters more than the original answer. Offering a way to settle body image rather than another opinion about it. Two…
Journal club: SURMOUNT-1, read without the press release Replied, post #16 · Evidence › Journal club · 19 Nov 2024 · 0 likes Post #12 and I disagree about the size of the effect, not about the direction. Summarising the SURMOUNT-1 thread so far, since it is long and the answer is buried: the…
Here for the analytics and not much else — one year on Replied, post #5 · Lounge › Introductions · 16 Nov 2024 · 2 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
Gallbladder disease risk with rapid weight loss Replied, post #31 · Clinical › Comorbidities · 15 Nov 2024 · 10 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
Asking about a compound your prescriber has not heard of — one year on Replied, post #3 · marked as the solution · Clinical › Prescriber conversations · 12 Nov 2024 · 9 likes Post #2 answers the question as asked. The question underneath it is different. Understanding stopping rules: what would prompt stopping the compound? Adverse effect,…
SURPASS-2 and the comparator dose question that will not go away Replied, post #53 · Compounds › Tirzepatide · 10 Nov 2024 · 7 likes Post #52 is the version of this I will quote in future. One addition. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is…
Time to steady state after a dose increase Replied, post #157 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 27 likes Dose proportionality across the studied range means dose arithmetic behaves the way you would naively expect. It is worth checking whether it holds for a given compound…
Irish differences from the UK position Replied, post #28 · Regional › UK & Ireland · 9 Oct 2024 · 3 likes Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating. Reporting the…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #9 · Wellbeing › Mental health · 29 Sep 2024 · 11 likes Where I part company with post #7, and it is a narrow parting. Social and relationship impacts: weight change affects how others perceive and interact with a person.…
Transit times by route, from a logged dataset — the long version Replied, post #14 · Sourcing › Logistics · 21 Sep 2024 · 2 likes Small methodological point on Transit times: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #31 · Analytics › Method validation · 11 Sep 2024 · 9 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
Blind submission and why it changes minds Replied, post #29 · Sourcing › Independent verification · 5 Aug 2024 · 7 likes Worth separating two things that post #27 runs together. An honest declaration on blind submission: I have a prior here and it is strong enough that you should weight…